Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AINovember 17, 2026

CANC Tema Oncology ETF

Fund tearsheet · data as of the latest session · November 17, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.99%expense ratio
$51Mfund assets
+16.0%return, YTD
—return, 1 year
—net flow, 1 month
—net flow, 1 year
24.3%realized volatility, 1y
-13.2%worst drawdown, 1y
Top ten holdings
1GMAB GENMAB A5.82%
2LLY ELI LILLY5.62%
3RVMD REVOLUTION MEDICINES5.34%
4MRK MERCK & CO5.03%
5ONC BeiGene4.34%
6COGT COGENT BIOSCIENCES4.31%
7ABBV ABBVIE3.88%
8EXEL EXELIXIS3.74%
9CGON CG ONCOLOGY INC2.89%
10BBIO BRIDGEBIO PHARMA3.20%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.